MRI and PET in monitoring response in lymphoma: Wednesday 5 October 2005, 08:30–10:00

The potential of FDG-PET and MRI in monitoring response to treatment in lymphoma is reviewed. Both FDG-PET and MRI can provide whole body imaging. Both also share the advantage of combining functional and anatomical information. At present, hybrid FDG-PET and MDCT is the best technique for monitorin...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahmouni, Alain, Luciani, Alain, Itti, Emmanuel
Formato: Texto
Lenguaje:English
Publicado: e-MED 2005
Materias:
Multidisciplinary Symposium: Haematological Malignancies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1665309/
https://www.ncbi.nlm.nih.gov/pubmed/16361125
http://dx.doi.org/10.1102/1470-7330.2005.0038
_version_ 1782131089442078720
author Rahmouni, Alain
Luciani, Alain
Itti, Emmanuel
author_facet Rahmouni, Alain
Luciani, Alain
Itti, Emmanuel
author_sort Rahmouni, Alain
collection PubMed
description The potential of FDG-PET and MRI in monitoring response to treatment in lymphoma is reviewed. Both FDG-PET and MRI can provide whole body imaging. Both also share the advantage of combining functional and anatomical information. At present, hybrid FDG-PET and MDCT is the best technique for monitoring response to treatment, especially early response to treatment. Early assessment of response to treatment has the potential to tailor therapy. MR imaging is useful especially in assessing bone marrow and central nervous system involvement.
format Text
id pubmed-1665309
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher e-MED
record_format MEDLINE/PubMed
spelling pubmed-16653092006-12-14 MRI and PET in monitoring response in lymphoma: Wednesday 5 October 2005, 08:30–10:00 Rahmouni, Alain Luciani, Alain Itti, Emmanuel Cancer Imaging Multidisciplinary Symposium: Haematological Malignancies The potential of FDG-PET and MRI in monitoring response to treatment in lymphoma is reviewed. Both FDG-PET and MRI can provide whole body imaging. Both also share the advantage of combining functional and anatomical information. At present, hybrid FDG-PET and MDCT is the best technique for monitoring response to treatment, especially early response to treatment. Early assessment of response to treatment has the potential to tailor therapy. MR imaging is useful especially in assessing bone marrow and central nervous system involvement. e-MED 2005-11-23 /pmc/articles/PMC1665309/ /pubmed/16361125 http://dx.doi.org/10.1102/1470-7330.2005.0038 Text en Copyright © 2005 International Cancer Imaging Society
spellingShingle Multidisciplinary Symposium: Haematological Malignancies
Rahmouni, Alain
Luciani, Alain
Itti, Emmanuel
MRI and PET in monitoring response in lymphoma: Wednesday 5 October 2005, 08:30–10:00
title MRI and PET in monitoring response in lymphoma: Wednesday 5 October 2005, 08:30–10:00
title_full MRI and PET in monitoring response in lymphoma: Wednesday 5 October 2005, 08:30–10:00
title_fullStr MRI and PET in monitoring response in lymphoma: Wednesday 5 October 2005, 08:30–10:00
title_full_unstemmed MRI and PET in monitoring response in lymphoma: Wednesday 5 October 2005, 08:30–10:00
title_short MRI and PET in monitoring response in lymphoma: Wednesday 5 October 2005, 08:30–10:00
title_sort mri and pet in monitoring response in lymphoma: wednesday 5 october 2005, 08:30–10:00
topic Multidisciplinary Symposium: Haematological Malignancies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1665309/
https://www.ncbi.nlm.nih.gov/pubmed/16361125
http://dx.doi.org/10.1102/1470-7330.2005.0038
work_keys_str_mv AT rahmounialain mriandpetinmonitoringresponseinlymphomawednesday5october200508301000
AT lucianialain mriandpetinmonitoringresponseinlymphomawednesday5october200508301000
AT ittiemmanuel mriandpetinmonitoringresponseinlymphomawednesday5october200508301000

Ejemplares similares